These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31775943)

  • 1. The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint.
    O'Rourke B; Werkö SS; Merlin T; Huang LY; Schuller T
    Int J Technol Assess Health Care; 2020; 36(1):1-4. PubMed ID: 31775943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the International Network of Agencies for Health Technology Assessment.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():24-7. PubMed ID: 19500434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstrating the influence of HTA: INAHTA member stories of HTA impact.
    Werkö SS; Merlin T; Lambert LJ; Fennessy P; Galán AP; Schuller T
    Int J Technol Assess Health Care; 2020 Nov; 37():e8. PubMed ID: 33148373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burning Issues in Health Technology Assessment and Policy Making: What's Keeping Senior Health Technology Assessment Users and Producers up at Night?
    Trowman R; Ollendorf DA; Sampietro-Colom L
    Int J Technol Assess Health Care; 2020; 36(1):5-7. PubMed ID: 32160939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INSIGHTS FROM THE FRONT LINES: A COLLECTION OF STORIES OF HTA IMPACT FROM INAHTA MEMBER AGENCIES.
    Schuller T; Söderholm Werkö S
    Int J Technol Assess Health Care; 2017 Jan; 33(4):409-410. PubMed ID: 29241477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of consumers in health technology assessment activities by Inahta agencies.
    Hailey D; Werkö S; Bakri R; Cameron A; Göhlen B; Myles S; Pwu J; Yothasamut J
    Int J Technol Assess Health Care; 2013 Jan; 29(1):79-83. PubMed ID: 23217279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies.
    Haji Ali Afzali H; Street J; Merlin T; Karnon J
    Int J Technol Assess Health Care; 2021 Jan; 37():e22. PubMed ID: 33455592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward transparency in health technology assessment: a checklist for HTA reports.
    Hailey D
    Int J Technol Assess Health Care; 2003; 19(1):1-7. PubMed ID: 12701934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES.
    Weeks L; Polisena J; Scott AM; Holtorf AP; Staniszewska S; Facey K
    Int J Technol Assess Health Care; 2017 Jan; 33(6):715-723. PubMed ID: 29122048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The International Network of Agencies for Health Technology Assessment (INAHTA) or the need for collaboration in evaluating health technologies].
    Asua Batarrita J
    Med Clin (Barc); 1999; 112 Suppl 1():86-9. PubMed ID: 10618805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta).
    Merlin T; Tamblyn D; Ellery B;
    Int J Technol Assess Health Care; 2014 Oct; 30(4):430-7. PubMed ID: 25397872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short history of INAHTA. International Network of Agencies for Health Technology Assessment.
    Hailey D; Menon D
    Int J Technol Assess Health Care; 1999; 15(1):236-42. PubMed ID: 10407609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topic selection process in health technology assessment agencies around the world: a systematic review.
    Qiu Y; Thokala P; Dixon S; Marchand R; Xiao Y
    Int J Technol Assess Health Care; 2022 Feb; 38(1):e19. PubMed ID: 35129112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on the involvement of consumers in health technology assessment programs.
    Hailey D; Nordwall M
    Int J Technol Assess Health Care; 2006; 22(4):497-9. PubMed ID: 16984683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing external risks to health technology assessment programs.
    Hailey D; Juzwishin D
    Int J Technol Assess Health Care; 2006; 22(4):429-35. PubMed ID: 16984675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint project of the International Network of Agencies for Health Technology Assessment--Part 2: Managing the diffusion of positron emission tomography with health technology assessment.
    Adams EJ; Almazán C; Mørland B; Bradbury I; King R; Rheinberger P
    Int J Technol Assess Health Care; 2006; 22(2):149-54. PubMed ID: 16571189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.